Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/10/2012US20120115837 Solid Preparation
05/10/2012US20120115836 Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens
05/10/2012US20120115835 Methods for treatment of bacterial infections
05/10/2012US20120115833 Method of treating hepatocellular carcinoma
05/10/2012US20120115832 TGR5 Modulators and Methods of Use Thereof
05/10/2012US20120115831 Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders
05/10/2012US20120115830 Assay methods for the determination of fkbpl expression level in the context of breast cancer
05/10/2012US20120115829 Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection
05/10/2012US20120115828 Medicinal cream containing miconazole nitrate, hydrocortisone acetate, and a biopolymer, and a process to make it
05/10/2012US20120115827 3-aminobenzamide compounds and vanilloid receptor subtype 1 (vr1) inhibitors
05/10/2012US20120115826 Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 AdrenergicReceptor
05/10/2012US20120115825 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof
05/10/2012US20120115824 Vitamin D Receptor Agonists and Uses Thereof
05/10/2012US20120115823 Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients
05/10/2012US20120115822 Use of 5h-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders
05/10/2012US20120115821 Composition and method for treating skin conditions
05/10/2012US20120115820 Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
05/10/2012US20120115819 Pentacycline Compounds
05/10/2012US20120115818 Synthesis of tetracyclines and intermediates thereto
05/10/2012US20120115817 Phthalimide derivatives of non-steroidal anti-inflammatory compounds and/or tnf-alpha modulators, method for producing same, pharmaceutical compositions containing same and uses thereof for the treatment of inflammatory diseases
05/10/2012US20120115815 Compositions useful especially for treatment or prevention of metabolic syndrome
05/10/2012US20120115814 Liquid Pharmaceutical Form Of Alkylphosphocholine And Method For Preparing Same
05/10/2012US20120115813 Boron-containing small molecules
05/10/2012US20120115812 Surface coatings for skin
05/10/2012US20120115811 Phenylanaline amide derivatives useful for treating insulin-related diseases and conditions
05/10/2012US20120115810 Surgical compositions for reducing the incidence of adhesions
05/10/2012US20120115809 Use of an acylated octasaccharide as an antithrombotic agent
05/10/2012US20120115808 Pharmacological preparation for topical use containing n-palmitoyl-vanillamide
05/10/2012US20120115807 Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350
05/10/2012US20120115806 Antitumor Combination Including Cabazitaxel and Capecitabine
05/10/2012US20120115805 Use of at least one nucleic acid to influence the natural pigmentation process
05/10/2012US20120115804 Compositions and methods for characterizing and treating neoplasia
05/10/2012US20120115803 Treatment of acinetobacter with alginate oligomers and antibiotics
05/10/2012US20120115802 Method for using ulipristal acetate with cytochrome isozyme modulators
05/10/2012US20120115801 Method for obtaining a stable dispersion of benzoyl peroxide
05/10/2012US20120115800 Pigment Aggregates
05/10/2012US20120115799 Pharmaceutical formulations
05/10/2012US20120115798 Method for improving the immunity of a companion animal
05/10/2012US20120115797 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
05/10/2012US20120115796 Novel Spacer Moiety for Poly(ehtylene Glycol) Modified Peptide Based Compounds
05/10/2012US20120115782 Compositions and methods for treating or inhibiting liver injury
05/10/2012US20120115781 Methods For Evaluating and Implementing Prostate Disease Treatments
05/10/2012US20120115778 Methods of Suppressing Appetite by the Administration of Antagonists of the Serotonin HTR1a or HTR2b Receptors or Inhibitors of TPH2
05/10/2012US20120115773 Modified omci as a complement inhibitor
05/10/2012US20120115728 Compositions containing anthraquinone derivatives as growth promoters and antifungal agents
05/10/2012US20120115161 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
05/10/2012US20120115136 Pna diagnostic use
05/10/2012US20120114831 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
05/10/2012US20120114823 Feed Additive For Improved Pigment Retention
05/10/2012US20120114776 Methods for preparing probiotic nanoparticles
05/10/2012US20120114767 System and Method for Diagnosis and Treatment of Neuropsychiatric Disorders
05/10/2012US20120114766 Substituted chroman derivatives, medicaments and use in therapy
05/10/2012US20120114765 Anti-neoplastic compounds, compositions and methods
05/10/2012US20120114759 Peptide/particle delivery systems
05/10/2012US20120114757 Particles comprising drospirenone encapsulated in a polymer
05/10/2012US20120114756 Sustained-release drug carrier composition
05/10/2012US20120114754 Rapidly disintegrating solid oral dosage form
05/10/2012US20120114753 Multi-layer tablet comprising effervescent layer
05/10/2012US20120114752 Stable tablet containing 4,5-epoxymorphinan derivative
05/10/2012US20120114751 Pharmaceutical composition for treating hcv infections
05/10/2012US20120114750 Pharmaceutical composition 271
05/10/2012US20120114748 Tanaproget Compositions Containing Ethinyl Estradiol
05/10/2012US20120114747 Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
05/10/2012US20120114745 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/10/2012US20120114744 Compositions and methods to treat muscular & cardiovascular disorders
05/10/2012US20120114743 Transdermal ricinoleic acid compositions
05/10/2012US20120114741 Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
05/10/2012US20120114740 Sustained release formulation of a non-steroidal anti-inflammatory drug
05/10/2012US20120114739 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
05/10/2012US20120114738 Transdermal patch
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114735 Compositions and methods for the treatment of throat discomfort
05/10/2012US20120114734 Nanostructure surface coated medical implants and methods of using the same
05/10/2012US20120114732 Elastin stabilization of connective tissue
05/10/2012US20120114731 Multilayer protein films, methods of making, and drug delivery devices and biomedical implants employing the films
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114714 Method for the treatment and prevention of erectile dysfunction
05/10/2012US20120114711 Pharmaceutical composition having improved solubility
05/10/2012US20120114710 Carbon nanotubes complexed with multiple bioactive agents and methods related thereto
05/10/2012US20120114709 Formulations for use in inhaler devices
05/10/2012US20120114706 Endorphin Therapy Compositions and Methods of Use Thereof
05/10/2012US20120114696 Small-molecule botulinum toxin inhibitors
05/10/2012US20120114689 Nicotinamide compositions for treatment of skin diseases and disorders
05/10/2012US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection
05/10/2012US20120114679 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/10/2012US20120114676 Methods of treating cancer with phenformin
05/10/2012US20120114670 Methods and compositions related to synergistic responses to oncogenic mutations
05/10/2012US20120114669 Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease
05/10/2012US20120114668 Method for modulating angiogenesis using fibromodulin
05/10/2012US20120114663 Methods to treat allergic conditions
05/10/2012US20120114661 Methods of identifying infectious disease and assays for identifying infectious disease
05/10/2012US20120114658 Treatment of cancer
05/10/2012US20120114657 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of Serotype IATS 01 of Pseudomonas Aeruginosa
05/10/2012US20120114643 4-pyridinone compounds and their use for cancer
05/10/2012US20120114641 Therapeutic combination comprising a plk1 inhibitor and an antineoplastic agent
05/10/2012US20120114639 Compositions and methods for inhibiting viral and/or bacterial infections
05/10/2012US20120114637 Mtor pathway inhibitors for treating ocular disorders
05/10/2012US20120114636 Low molecular weight cyclin e (lmw-e) as a biomarker for personalization of cancer therapies
05/10/2012US20120114633 Inhibitors Of Bacterial Type III Secretion System
05/10/2012US20120114628 Cosmetic and therapeutic use of proteins of dj-1 type for treating skin dryness
1 ... 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 ... 7860